Published in Int J Radiat Oncol Biol Phys on March 15, 2003
Proton beam therapy. Br J Cancer (2005) 1.46
Monte Carlo calculations and measurements of absorbed dose per monitor unit for the treatment of uveal melanoma with proton therapy. Phys Med Biol (2008) 1.20
Review of clinical experience with ion beam radiotherapy. Br J Radiol (2011) 0.91
Radiotherapy for ocular tumours. Eye (Lond) (2012) 0.90
Proton beam radiotherapy in the management of uveal melanoma: Clinical experience in Scotland. Clin Ophthalmol (2009) 0.84
Differences in uveal melanomas between men and women from the British Isles. Eye (Lond) (2011) 0.83
[Endoresection following proton beam irradiation of large uveal melanomas]. Ophthalmologe (2004) 0.80
Proton beam radiotherapy of uveal melanoma. Saudi J Ophthalmol (2013) 0.78
Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma. Eye (Lond) (2015) 0.77
The effectiveness and safety of proton radiation therapy for indications of the eye : a systematic review. Strahlenther Onkol (2009) 0.76
Assessment of the effect of iris colour and having children on 5-year risk of death after diagnosis of uveal melanoma: a follow-up study. BMC Ophthalmol (2014) 0.76
Protons, Photons, and the Prostate - Is There Emerging Evidence in the Ongoing Discussion on Particle Therapy for the Treatment of Prostate Cancer? Front Oncol (2016) 0.75
Identification of novel chemotherapeutic strategies for metastatic uveal melanoma. Sci Rep (2017) 0.75
Secondary neutron dose measurement for proton eye treatment using an eye snout with a borated neutron absorber. Radiat Oncol (2013) 0.75
Preliminary results of proton radiotherapy for choroidal melanoma - the Kraków experience. Contemp Oncol (Pozn) (2014) 0.75
Clinical and Research Activities at the CATANA Facility of INFN-LNS: From the Conventional Hadrontherapy to the Laser-Driven Approach. Front Oncol (2017) 0.75
Mechanisms of phosphenes in irradiated patients. Oncotarget (2017) 0.75
Intravitreal ranibizumab (Lucentis) in the treatment of retinal angiomatous proliferation (RAP). Graefes Arch Clin Exp Ophthalmol (2009) 2.19
Peripheral exudative hemorrhagic chorioretinopathy: a clinical, angiographic, and histologic study. Am J Ophthalmol (2009) 1.91
Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas. Radiother Oncol (2004) 1.81
Treatment planning and verification of proton therapy using spot scanning: initial experiences. Med Phys (2004) 1.69
The clinical potential of intensity modulated proton therapy. Z Med Phys (2004) 1.59
Mutations in PIP5K3 are associated with François-Neetens mouchetée fleck corneal dystrophy. Am J Hum Genet (2005) 1.35
Bietti's crystalline corneoretinal dystrophy: a cross-sectional study. Retina (2004) 1.31
Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report. Int J Radiat Oncol Biol Phys (2009) 1.28
Lack of BRAF mutations in uveal melanoma. Cancer Res (2003) 1.27
Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of the skull base: the Paul Scherrer Institut experience. Int J Radiat Oncol Biol Phys (2005) 1.23
Metastatic melanoma in the eye and orbit. Ophthalmology (2003) 1.22
Intravitreal ranibizumab (Lucentis) for the treatment of myopic choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol (2008) 1.20
Peripheral exudative hemorrhagic chorioretinopathy: polypoidal choroidal vasculopathy and hemodynamic modifications. Am J Ophthalmol (2012) 1.01
Intravitreal ranibizumab in the treatment of choroidal neovascularization associated with idiopathic central serous chorioretinopathy. Eur J Ophthalmol (2010) 1.00
Genetic linkage of Francois-Neetens fleck (mouchetée) corneal dystrophy to chromosome 2q35. Hum Genet (2003) 0.99
Postoperative proton radiotherapy for localized and locoregional breast cancer: potential for clinically relevant improvements? Int J Radiat Oncol Biol Phys (2009) 0.97
Chorioretinitis induced by intravesical Bacillus Calmette-Guérin (BCG) instillations for urinary bladder carcinoma. Klin Monbl Augenheilkd (2003) 0.95
Tumors of the caruncle: a clinicopathologic correlation. Am J Ophthalmol (2006) 0.95
Postoperative spot-scanning proton radiation therapy for chordoma and chondrosarcoma in children and adolescents: initial experience at paul scherrer institute. Int J Radiat Oncol Biol Phys (2008) 0.95
Unilateral conjunctival-corneal argyrosis simulating conjunctival melanoma. Arch Ophthalmol (2003) 0.95
Spot-scanning proton therapy for malignant soft tissue tumors in childhood: First experiences at the Paul Scherrer Institute. Int J Radiat Oncol Biol Phys (2006) 0.94
Sensitivity of intensity modulated proton therapy plans to changes in patient weight. Radiother Oncol (2008) 0.94
Experiences at the Paul Scherrer Institute with a remote patient positioning procedure for high-throughput proton radiation therapy. Int J Radiat Oncol Biol Phys (2008) 0.93
Extracranial chordoma: Outcome in patients treated with function-preserving surgery followed by spot-scanning proton beam irradiation. Int J Radiat Oncol Biol Phys (2006) 0.93
Spot scanning-based proton therapy for intracranial meningioma: long-term results from the Paul Scherrer Institute. Int J Radiat Oncol Biol Phys (2011) 0.91
Primary choroidal melanoma in phakomatosis pigmentovascularis IIa. Ophthalmology (2005) 0.91
Baerveldt shunts in the treatment of glaucoma secondary to anterior uveal melanoma and proton beam radiotherapy. Br J Ophthalmol (2012) 0.90
How would you manage this small melanocytic choroidal tumour? Small choroidal melanoma hiding a large extrascleral extension. Br J Ophthalmol (2012) 0.90
Early clinical experience with ranibizumab for occult and minimally classic neovascular membranes in age-related macular degeneration. Ophthalmologica (2008) 0.90
(18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study. Melanoma Res (2012) 0.89
Adjuvant intra-arterial hepatic fotemustine for high-risk uveal melanoma patients. Melanoma Res (2008) 0.89
Peripapillary choroidal neovascularization associated with melanocytoma of the optic disc: a clinicopathologic case report. Graefes Arch Clin Exp Ophthalmol (2006) 0.89
Novel technique of craniospinal axis proton therapy with the spot-scanning system: avoidance of patching multiple fields and optimized ventral dose distribution. Strahlenther Onkol (2007) 0.87
Retinal pigment epithelium tears after intravitreal injection of ranibizumab for predominantly classic neovascular membranes secondary to age-related macular degeneration. Acta Ophthalmol (2010) 0.86
Phenotypic variability of retinocytomas: preregression and postregression growth patterns. Br J Ophthalmol (2012) 0.86
The PSI Gantry 2: a second generation proton scanning gantry. Z Med Phys (2004) 0.86
New developments in external beam radiotherapy for retinoblastoma: from lens to normal tissue-sparing techniques. Clin Experiment Ophthalmol (2008) 0.86
Melanocytomas of the optic disk. Am J Ophthalmol (2004) 0.85
Relative biologic effectiveness determination in mouse intestine for scanning proton beam at Paul Scherrer Institute, Switzerland. Influence of motion. Int J Radiat Oncol Biol Phys (2005) 0.85
(106)Ruthenium brachytherapy for retinoblastoma. Int J Radiat Oncol Biol Phys (2008) 0.85
Spot-scanning-based proton therapy for extracranial chordoma. Int J Radiat Oncol Biol Phys (2011) 0.85
Role of vitreoretinal surgery in maximizing treatment outcome following complications after proton therapy for uveal melanoma. Retina (2013) 0.84
Swedish protons. Acta Oncol (2005) 0.84
Deep propofol sedation for vacuum-assisted bite-block immobilization in children undergoing proton radiation therapy of cranial tumors. Paediatr Anaesth (2007) 0.83
Systemic melanoma metastatic to the retina and vitreous. Ophthalmologica (2004) 0.82
Metastatic choroidal paraganglioma. Ophthalmology (2011) 0.82
Temporal lobe toxicity analysis after proton radiation therapy for skull base tumors. Int J Radiat Oncol Biol Phys (2012) 0.82
Spot-scanning proton radiation therapy for pediatric chordoma and chondrosarcoma: clinical outcome of 26 patients treated at paul scherrer institute. Int J Radiat Oncol Biol Phys (2013) 0.82
Utility of a biopsy in suspicious pigmented iris tumors. Ophthalmic Res (2008) 0.82
Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study. Int J Radiat Oncol Biol Phys (2005) 0.81
Choroidal metastases in testicular choriocarcinoma, successful treatment with chemo- and radiotherapy: a case report. BMC Urol (2011) 0.81
Non-neural regions of the adult human eye: a potential source of neurons? Invest Ophthalmol Vis Sci (2003) 0.81
Dose to the developing dentition during therapeutic irradiation: organ at risk determination and clinical implications. Int J Radiat Oncol Biol Phys (2013) 0.80
Successful treatment of longstanding vasospastic central retinal artery occlusion. Acta Ophthalmol (2009) 0.79
[Eye and Cancer]. Rev Med Suisse (2015) 0.79
Intravitreal ranibizumab as primary treatment for neovascular membrane associated with idiopathic juxtafoveal retinal telangiectasia. Graefes Arch Clin Exp Ophthalmol (2009) 0.79
["Spot-scanning" proton therapy for rhabdomyosarcomas of early childhood. First experiences at PSI]. Strahlenther Onkol (2006) 0.79
Spot scanning proton therapy in the curative treatment of adult patients with sarcoma: the Paul Scherrer institute experience. Int J Radiat Oncol Biol Phys (2007) 0.78
Chiasmatic infiltration secondary to late malignant transformation of retinoma. Ophthalmic Genet (2011) 0.77
Clinical and genetic investigation of a large Tunisian family with complete achromatopsia: identification of a new nonsense mutation in GNAT2 gene. J Hum Genet (2010) 0.77
Subclinical experimental optic neuropathy after accelerated proton beam irradiation. Ophthalmologica (2003) 0.76
Spontaneous regression of an isolated retinal astrocytic hamartoma. Retina (2005) 0.76
Blackening of choroidal hemangioma after tantalum clip surgery. Arch Ophthalmol (2007) 0.76
Peculiar findings in a case of bilateral uveal pigmented lesions. Ocul Immunol Inflamm (2010) 0.76
Conjunctival intraepithelial neoplasia in a patient treated with tacrolimus after liver transplantation. Cornea (2007) 0.76
Optimal treatment of retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol (2009) 0.75
A clinical study of annular cyclitis. Clin Ophthalmol (2009) 0.75
Clinicopathologic and molecular analysis of a choroidal pigmented schwannoma in the context of a PTEN hamartoma tumor syndrome. Ophthalmology (2012) 0.75
Bilateral circumscribed choroidal hemangioma in an otherwise healthy individual. Retin Cases Brief Rep (2007) 0.75
Proton spot scanning radiotherapy of spontaneous canine tumors. Vet Radiol Ultrasound (2009) 0.75
Conjunctival pigmented epithelioid melanocytoma: a clinicopathological case report. Arch Ophthalmol (2012) 0.75
Evanescent vaso-occlusive choroidal pseudo-tumor with acute painful onset: a presumed vortex vein occlusion. Graefes Arch Clin Exp Ophthalmol (2013) 0.75
Infliximab therapy for a severe case of IgG4-related ocular adnexal disorder recalcitrant to corticosteroid treatment. Ocul Immunol Inflamm (2012) 0.75